This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04693/identifier/pdb/
n11http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB04693/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04693/identifier/pubchem-substance/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04693/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04693
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB04693 n11:DB04693
dcterms:title
(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE
adms:identifier
n4:5288172 n10:DB04693 n12:46506451 n13:ESR
n5:IUPAC-Name
n6:271B4A61-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4A67-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4A66-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4A63-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4A64-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4A65-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4A5F-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4A5D-363D-11E5-9242-09173F13E4C5 n6:271B4A60-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4A5E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4A6D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4A6E-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4A68-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4A69-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4A6B-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4A6A-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4A6C-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4A73-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4A75-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4A76-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4A72-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4A71-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4A74-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4A62-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4A6F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4A70-363D-11E5-9242-09173F13E4C5